pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-202 |
Genomic Coordinates | chr10: 133247511 - 133247620 |
Synonyms | MIRN202, hsa-mir-202, MIR202 |
Description | Homo sapiens miR-202 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-202-3p | ||||||||||||||||||||||||
Sequence | 64| AGAGGUAUAGGGCAUGGGAA |83 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FXN | ||||||||||||||||||||
Synonyms | CyaY, FA, FARR, FRDA, X25 | ||||||||||||||||||||
Description | frataxin | ||||||||||||||||||||
Transcript | NM_181425 | ||||||||||||||||||||
Other Transcripts | NM_001161706 , NM_000144 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FXN | |||||||||||||||||||||
3'UTR of FXN (miRNA target sites are highlighted) |
>FXN|NM_181425|3'UTR 1 AAACCAAACTGGACTTGTCTTCCTTGGCCTATTCCGGAAAAGATGCTTGATGCCCAGCCCCGTTTTAAGGACATTAAAAG 81 CTATCAGGCCAAGACCCCAGCTTCATTATGCAGCTGAGGTCTGTTTTTTGTTGTTGTTGTTGTTTATTTTTTTTATTCCT 161 GCTTTTGAGGACAGTTGGGCTATGTGTCACAGCTCTGTAGAAAGAATGTGTTGCCTCCTACCTTGCCCCCAAGTTCTGAT 241 TTTTAATTTCTATGGAAGATTTTTTGGATTGTCGGATTTCCTCCCTCACATGATACCCCTTATCTTTTATAATGTCTTAT 321 GCCTATACCTGAATATAACAACCTTTAAAAAAGCAAAATAATAAGAAGGAAAAATTCCAGGAGGGAAAATGAATTGTCTT 401 CACTCTTCATTCTTTGAAGGATTTACTGCAAGAAGTACATGAAGAGCAGCTGGTCAACCTGCTCACTGTTCTATCTCCAA 481 ATGAGACACATTAAAGGGTAGCCTACAAATGTTTTCAGGCTTCTTTCAAAGTGTAAGCACTTCTGAGCTCTTTAGCATTG 561 AAGTGTCGAAAGCAACTCACACGGGAAGATCATTTCTTATTTGTGCTCTGTGACTGCCAAGGTGTGGCCTGCACTGGGTT 641 GTCCAGGGAGACCTAGTGCTGTTTCTCCCACATATTCACATACGTGTCTGTGTGTATATATATTTTTTCAATTTAAAGGT 721 TAGTATGGAATCAGCTGCTACAAGAATGCAAAAAATCTTCCAAAGACAAGAAAAGAGGAAAAAAAGCCGTTTTCATGAGC 801 TGAGTGATGTAGCGTAACAAACAAAATCATGGAGCTGAGGAGGTGCCTTGTAAACATGAAGGGGCAGATAAAGGAAGGAG 881 ATACTCATGTTGATAAAGAGAGCCCTGGTCCTAGACATAGTTCAGCCACAAAGTAGTTGTCCCTTTGTGGACAAGTTTCC 961 CAAATTCCCTGGACCTCTGCTTCCCCATCTGTTAAATGAGAGAATAGAGTATGGTTGATTCCCAGCATTCAGTGGTCCTG 1041 TCAAGCAACCTAACAGGCTAGTTCTAATTCCCTATTGGGTAGATGAGGGGATGACAAAGAACAGTTTTTAAGCTATATAG 1121 GAAACATTGTTATTGGTGTTGCCCTATCGTGATTTCAGTTGAATTCATGTGAAAATAATAGCCATCCTTGGCCTGGCGCG 1201 GTGGCTCACACCTGTAATCCCAGCACTTTTGGAGGCCAAGGTGGGTGGATCACCTGAGGTCAGGAGTTCAAGACCAGCCT 1281 GGCCAACATGATGAAACCCCGTCTCTACTAAAAATACAAAAAATTAGCCGGGCATGATGGCAGGTGCCTGTAATCCCAGC 1361 TACTTGGGAGGCTGAAGCGGAAGAATCGCTTGAACCCAGAGGTGGAGGTTGCAGTGAGCCGAGATCGTGCCATTGCACTG 1441 TAACCTGGGTGACTGAGCAAAACTCTGTCTCAAAATAATAATAACAATATAATAATAATAATAGCCATCCTTTATTGTAC 1521 CCTTACTGGGTTAATCGTATTATACCACATTACCTCATTTTAATTTTTACTGACCTGCACTTTATACAAAGCAACAAGCC 1601 TCCAGGACATTAAAATTCATGCAAAGTTATGCTCATGTTATATTATTTTCTTACTTAAAGAAGGATTTATTAGTGGCTGG 1681 GCATGGTGGCGTGCACCTGTAATCCCAGGTACTCAGGAGGCTGAGACGGGAGAATTGCTTGACCCCAGGCGGAGGAGGTT 1761 ACAGTGAGTCGAGATCGTACCTGAGCGACAGAGCGAGACTCCGTCTCAAAAAAAAAAAAAAGGAGGGTTTATTAATGAGA 1841 AGTTTGTATTAATATGTAGCAAAGGCTTTTCCAATGGGTGAATAAAAACACATTCCATTAAGTCAAGCTGGGAGCAGTGG 1921 CATATACCTATAGTCCCAGCTGCACAGGAGGCTGAGACAGGAGGATTGCTTGAAGCCAGGAATTGGAGATCAGCCTGGGC 2001 AACACAGCAAGATCCTATCTCTTAAAAAAAGAAAAAAAAACCTATTAATAATAAAACAGTATAAACAAAAGCTAAATAGG 2081 TAAAATATTTTTTCTGAAATAAAATTATTTTTTGAGTCTGATGGAAATGTTTAAGTGCAGTAGGCCAGTGCCAGTGAGAA 2161 AATAAATAACATCATACATGTTTGTATGTGTTTGCATCTTGCTTCTACTGAAAGTTTCAGTGCACCCCACTTACTTAGAA 2241 CTCGGTGACATGATGTACTCCTTTATCTGGGACACAGCACAAAAGAGGTATGCAGTGGGGCTGCTCTGACATGAAAGTGG 2321 AAGTTAAGGAATCTGGGCTCTTATGGGGTCCTTGTGGGCCAGCCCTTCAGGCCTATTTTACTTTCATTTTACATATAGCT 2401 CTAATTGGTTTGATTATCTCGTTCCCAAGGCAGTGGGAGATCCCCATTTAAGGAAAGAAAAGGGGCCTGGCACAGTGGCT 2481 CATGCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCAAGTGTATCACCTGAGGTCAGGAGTTCAAGACCAGCCTGGCCAA 2561 CATGGCAAAATCCCGTCTCTACTAAAAATATTAAAAAATTGGCTGGGCGTGGTGGTTCGTGCCTATAATTTCAGCTACTC 2641 AGGAGGCTGAGGCAGGAGAATCGCTGTAACCTGGGGGGTGGAGGTTGCAGTGAGACGAGATCATGCCACTTCACTCCAGC 2721 CTGGCCAACAGAGCCATACTCCGTCTCAAATAAATAAATAAATAAATAAAGGGACTTCAAACACATGAACAGCAGCCAGG 2801 GGAAGAATCAAAATCATATTCTGTCAAGCAAACTGGAAAAGTACCACTGTGTGTACCAATAGCCTCCCCACCACAGACCC 2881 TGGGAGCATCGCCTCATTTATGGTGTGGTCCAGTCATCCATGTGAAGGATGAGTTTCCAGGAAAAGGTTATTAAATATTC 2961 ACTGTAACATACTGGAGGAGGTGAGGAATTGCATAATACAATCTTAGAAAACTTTTTTTTCCCCTTTCTATTTTTTGAGA 3041 CAGGATCTCACTTTGGCACTCAGGCTGGAGGACAGTGGTACAATCAAAGCTCATGGCAGCCTCGACCTCCCTGGGCTTGG 3121 GCAATCCTCCCACAGGTGTGCACCTCCATAGCTGGCTAATTTGTGTATTTTTTGTAGAGATGGGGTTTCACCATGTTGCC 3201 CAGGCTGGTCTCTAACACTTAGGCTCAAGTGATCCACCTGCCTCGTCCTCCCAAGATGCTGGGATTACAGGTGTGTGCCA 3281 CAGGTGTTCATCAGAAAGCTTTTTCTATTATTTTTACCTTCTTGAGTGGGTAGAACCTCAGCCACATAGAAAATAAAATG 3361 TTCTGGCATGACTTATTTAGCTCTCTGGAATTACAAAGAAGGAATGAGGTGTGTAAAAGAGAACCTGGGTTTTTGAATCA 3441 CAAATTTAGAATTTAATCGAAACTCTGCCTCTTACTTGTTTGTAGACACTGACAGTGGCCTCATGTTTTTTTTTTTTTTA 3521 ATCTATAAAATGGAGATATCTAACATGTTGAGCCTGGGCCCACAGGCAAAGCACAATCCTGATGTGAGAAGTACTCAGTT 3601 CATGACAACTGTTGTTCTCACATGCATAGCATAATTTCATATTCACATTGGAGGACTTCTCCCAAAATATGGATGACGTT 3681 CCCTACTCAACCTTGAACTTAATCAAAATACTCAGTTTACTTAACTTCGTATTAGATTCTGATTCCCTGGAACCATTTAT 3761 CGTGTGCCTTACCATGCTTATATTTTACTTGATCTTTTGCATACCTTCTAAAACTATTTTAGCCAATTTAAAATTTGACA 3841 GTTTGCATTAAATTATAGGTTTACAATATGCTTTATCCAGCTATACCTGCCCCAAATTCTGACAGATGCTTTTGCCACCT 3921 CTAAAGGAAGACCCATGTTCATAGTGATGGAGTTTGTGTGGACTAACCATGCAAGGTTGCCAAGGAAAAATCGCTTTACG 4001 CTTCCAAGGTACACACTAAGATGAAAGTAATTTTAGTCCGTGTCCAGTTGGATTCTTGGCACATAGTTATCTTCTGCTAG 4081 AACAAACTAAAACAGCTACATGCCAGCAAGGGAGAAAGGGGAAGGAGGGGCAAAGTTTTGAAATTTCATGTAAATTTATG 4161 CTGTTCAAAACGACGAGTTCATGACTTTGTGTATAGAGTAAGAAATGCCTTTTCTTTTTTGAGACAGAGTCTTGCTCTGT 4241 CACCCAGGCTGGAGTGCAGTGGCACGATCTGGGCTCACTACAACCTCCGCCTCCTGGGTTCAAGCAATTCTCTGCCTCAG 4321 CCTCCCGAGTAGCTGGGATTACAGGTGCCTGCCACCACACCCGGCTAATTTTTGTATTTTTAGTAGAGACGGGGTTTCAC 4401 CATCATGGCCAGGCTGGTCTTGAACTCCTGACCTAGTAATCCACCTGCCTCCGCCTCCCAAAGTGCTGGGATTACAGGCG 4481 TGAGCCACTGCACCCAGCCAGAAATGCCTTCTAATCTTTGGTTTATCTTAATTAGCCAGGACACTTGGAGTGCATCCCGA 4561 AGTACCTGATCAGTGGCCCCTTTGGAATGTGTAAAACTCAGCTCACTTATATCCCTGCATCCGCTACAGAGACAGAATCC 4641 AAGCTCATATGTTCCATCTTCTCTGGCTGTATAGTTTAAGGAATGGAAGGCACCAGAACAGATTTATTGAAATGTTTATT 4721 AGCTGAAGATTTATTTAGACAGTTGAGGAAAACATCAGCACCCAGCAGTAAAATTGGCTCTCAAAGATTTTCTTCTCCTG 4801 TGGAAAGTCAGACCTCTGAGGCCCCATCCAGGTAGAAGTACTAGTGCAAGAAGGGCCTCTGCTGTCCACTTGTGTTTCTG 4881 TGATCTGTGGGAACATTGTTAACGCCACATCTTGACCTCAAATTGTTTAGCTCCTGGCCAGACACGGTGGCTCACACCTG 4961 TAATCCCAGCACTTTGAGAGGCTGAGGCAGGTGGATCACCTGAGGTTAGGAGTTCGAGGCCAGCCTGGTCAACATGGTAA 5041 AACCCCGCCTCTACTAAAAATACAAAAATTAGCTGGCCGTAGTGGCGCACGCCTGTTATCCCAGCTACTCGGGAGGCTGA 5121 GGCAGGAGAATTGCTTGAACCTGGGTGGTGGAGGTTGCAGTGAGCCGAGATTACACCACTGCACTCCAGCCTGGGTGACA 5201 AGAGGGAAACTCCATTAAAAAAATGTAATTCCCGTGTCTGCCATCTTAAGTGTAAAGGTGGCTAAATTATATAGAAAAAT 5281 AAGACAATATCATTTCCCAATTACATTCCTTTCCTACCGCACTCTATGATGCTAGCTGAGATTTTTCCAAAAGAAAATGG 5361 CTTAAATAAAACCCTAAGAGAAAGAAAAACTTTAAATCCCTCCAAAGCTCAAAAGTAATAGAAACAGATGAGTTTGGAGT 5441 CAGGATTTCTCTGTAAGATTGCCTAGGCTGTGTACTGCACATCTCCAGGTGCCACTGTTGACAGAGATTATAACTACAAT 5521 GTGAAGTGAATGGTGCCACTGACAGTTATGCAAACCGTCCAGAGCATAGCCACCTGATCCTGCTGGGATTCCTCTTGCCA 5601 GTCCATCAGCAGTTCCCCTTGAAAGTTTCACCAAACATCCCTTAAATCTGCCCTCTCCTGCCCGTCCCCAGTGGAGGTCC 5681 TCATCATTTTTCACCTGCATTTTTGCAGGAGCTTTCTTATATCCACCTTCCTCCTTTTCTCTCAGCCCATCATCTAGCTA 5761 CACAGTCTCCAGGGTAAGCTTTCAGAAAGGCAATCTCTTGTCTGTAAAACCTAAGCAGGACCAAGGCCAAGTTTCTTAGC 5841 CTGAAAAATGTGCTTTTCTGACTGAACTGTTCAGGCACTGACTCTACATATAATTATGCTTTTCTACCCCCTCACACTCA 5921 ACACTTTGACTCCAGCAATCCCAAATCCCCAGATCCCTAAGTGTGCTGTGCTATTTTCACGTGGCTCTCAGACTTGGCCA 6001 GTGCTGTTTCCATTTTGGTCTTTATTCCCCACATCTCTGCCTGGGGGGTAGATTCTACCCTGAAAAATGTTCTTGGCACA 6081 GCCTTGCAAACTCCTCCTCCACTCAGCCTCTGCCTGGATGCCCTTGATTGTTCCATGTCCTCAGCATACCATGTTTGTCT 6161 TTCCCAGCACTGACCTACCATGTGTCACCCCTGCTTGGCTGTACCTTCCATGAGGCTAGGACTATGTGTCTCCTTTGTTG 6241 ACTGCTGTTGCCCTAGCATCTTGCACAGTTCCTTGCACACAATTAGAGCTCTATAAATGTCAAATAAATGTGTTATAATT 6321 ATATGTTTAAGATAGTTGTTCAAATAAACTCTAAATAACCCCAAC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000396366.2 | 3UTR | UAUUAUACCACAUUACCUCAUUUUAAUUUUUACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
187 hsa-miR-202-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT016613 | MYCN | MYCN proto-oncogene, bHLH transcription factor | 1 | 1 | ||||||||
MIRT053565 | GLI1 | GLI family zinc finger 1 | 3 | 1 | ||||||||
MIRT063201 | ADIPOR2 | adiponectin receptor 2 | 2 | 2 | ||||||||
MIRT067406 | TMTC3 | transmembrane and tetratricopeptide repeat containing 3 | 2 | 2 | ||||||||
MIRT068548 | NHLRC3 | NHL repeat containing 3 | 2 | 6 | ||||||||
MIRT080404 | ONECUT2 | one cut homeobox 2 | 2 | 2 | ||||||||
MIRT118591 | STK4 | serine/threonine kinase 4 | 2 | 2 | ||||||||
MIRT123324 | CALU | calumenin | 2 | 2 | ||||||||
MIRT191784 | LIN52 | lin-52 DREAM MuvB core complex component | 2 | 2 | ||||||||
MIRT194243 | FAM103A1 | family with sequence similarity 103 member A1 | 2 | 6 | ||||||||
MIRT252856 | ZNF526 | zinc finger protein 526 | 2 | 4 | ||||||||
MIRT268844 | C1ORF21 | chromosome 1 open reading frame 21 | 2 | 2 | ||||||||
MIRT273603 | SP1 | Sp1 transcription factor | 2 | 2 | ||||||||
MIRT363747 | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | 2 | 2 | ||||||||
MIRT437760 | HAS2 | hyaluronan synthase 2 | 1 | 1 | ||||||||
MIRT437971 | LRP6 | LDL receptor related protein 6 | 3 | 1 | ||||||||
MIRT438223 | ARL5A | ADP ribosylation factor like GTPase 5A | 2 | 1 | ||||||||
MIRT442013 | NDUFA4P1 | NDUFA4, mitochondrial complex associated pseudogene 1 | 2 | 2 | ||||||||
MIRT445652 | ATP6V1G1 | ATPase H+ transporting V1 subunit G1 | 2 | 6 | ||||||||
MIRT448241 | ZNF774 | zinc finger protein 774 | 2 | 2 | ||||||||
MIRT452085 | NUCB2 | nucleobindin 2 | 2 | 2 | ||||||||
MIRT454158 | HIST1H2BK | histone cluster 1 H2B family member k | 2 | 2 | ||||||||
MIRT454273 | FXN | frataxin | 2 | 2 | ||||||||
MIRT455669 | GLO1 | glyoxalase I | 2 | 2 | ||||||||
MIRT458010 | MRPL12 | mitochondrial ribosomal protein L12 | 2 | 2 | ||||||||
MIRT458272 | FUT10 | fucosyltransferase 10 | 2 | 2 | ||||||||
MIRT463411 | ZC3HAV1L | zinc finger CCCH-type containing, antiviral 1 like | 2 | 2 | ||||||||
MIRT463655 | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 2 | 2 | ||||||||
MIRT465107 | TSC22D2 | TSC22 domain family member 2 | 2 | 4 | ||||||||
MIRT470409 | PPP1R15B | protein phosphatase 1 regulatory subunit 15B | 2 | 2 | ||||||||
MIRT470662 | POLR2D | RNA polymerase II subunit D | 2 | 4 | ||||||||
MIRT470842 | PLXND1 | plexin D1 | 2 | 2 | ||||||||
MIRT471411 | PDP2 | pyruvate dehyrogenase phosphatase catalytic subunit 2 | 2 | 2 | ||||||||
MIRT471519 | PCGF3 | polycomb group ring finger 3 | 2 | 6 | ||||||||
MIRT472668 | NAA20 | N(alpha)-acetyltransferase 20, NatB catalytic subunit | 2 | 2 | ||||||||
MIRT473124 | MLLT10 | MLLT10, histone lysine methyltransferase DOT1L cofactor | 2 | 2 | ||||||||
MIRT474252 | LATS2 | large tumor suppressor kinase 2 | 2 | 2 | ||||||||
MIRT474485 | KLHDC8B | kelch domain containing 8B | 2 | 2 | ||||||||
MIRT474753 | KIAA0930 | KIAA0930 | 2 | 2 | ||||||||
MIRT474899 | KCTD21 | potassium channel tetramerization domain containing 21 | 2 | 2 | ||||||||
MIRT476815 | FNDC3A | fibronectin type III domain containing 3A | 2 | 2 | ||||||||
MIRT477669 | EFHD2 | EF-hand domain family member D2 | 2 | 2 | ||||||||
MIRT477739 | EDN1 | endothelin 1 | 2 | 2 | ||||||||
MIRT479745 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT480332 | C5orf51 | chromosome 5 open reading frame 51 | 2 | 10 | ||||||||
MIRT481188 | ATXN7L3B | ataxin 7 like 3B | 2 | 4 | ||||||||
MIRT481228 | ATXN7L3 | ataxin 7 like 3 | 2 | 2 | ||||||||
MIRT481357 | ATG9A | autophagy related 9A | 2 | 2 | ||||||||
MIRT481645 | AREL1 | apoptosis resistant E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT485486 | IGF1R | insulin like growth factor 1 receptor | 2 | 8 | ||||||||
MIRT490467 | ABT1 | activator of basal transcription 1 | 2 | 8 | ||||||||
MIRT492050 | TNFSF9 | TNF superfamily member 9 | 2 | 2 | ||||||||
MIRT492621 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 2 | 2 | ||||||||
MIRT494680 | ARID3A | AT-rich interaction domain 3A | 2 | 2 | ||||||||
MIRT497868 | SLC12A7 | solute carrier family 12 member 7 | 2 | 2 | ||||||||
MIRT498111 | PLEKHO1 | pleckstrin homology domain containing O1 | 2 | 4 | ||||||||
MIRT498793 | MDM2 | MDM2 proto-oncogene | 2 | 2 | ||||||||
MIRT499342 | RAB25 | RAB25, member RAS oncogene family | 2 | 2 | ||||||||
MIRT499398 | PLCG2 | phospholipase C gamma 2 | 2 | 4 | ||||||||
MIRT499646 | SDR42E1 | short chain dehydrogenase/reductase family 42E, member 1 | 2 | 2 | ||||||||
MIRT500805 | THBS1 | thrombospondin 1 | 2 | 3 | ||||||||
MIRT501194 | SUMO1 | small ubiquitin-like modifier 1 | 2 | 2 | ||||||||
MIRT501225 | SEMA4C | semaphorin 4C | 2 | 6 | ||||||||
MIRT501317 | RNFT1 | ring finger protein, transmembrane 1 | 2 | 2 | ||||||||
MIRT501341 | RNF44 | ring finger protein 44 | 2 | 4 | ||||||||
MIRT501381 | RBFOX2 | RNA binding protein, fox-1 homolog 2 | 2 | 10 | ||||||||
MIRT501683 | PDE12 | phosphodiesterase 12 | 2 | 8 | ||||||||
MIRT501923 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT501933 | MBD2 | methyl-CpG binding domain protein 2 | 2 | 8 | ||||||||
MIRT502118 | KMT2D | lysine methyltransferase 2D | 2 | 4 | ||||||||
MIRT502260 | HNRNPC | heterogeneous nuclear ribonucleoprotein C (C1/C2) | 2 | 2 | ||||||||
MIRT502766 | CLDN12 | claudin 12 | 2 | 6 | ||||||||
MIRT502831 | CELF1 | CUGBP Elav-like family member 1 | 2 | 2 | ||||||||
MIRT505007 | ZNF644 | zinc finger protein 644 | 2 | 2 | ||||||||
MIRT505571 | SMC1A | structural maintenance of chromosomes 1A | 2 | 6 | ||||||||
MIRT506930 | IGDCC4 | immunoglobulin superfamily DCC subclass member 4 | 2 | 6 | ||||||||
MIRT507238 | FIGN | fidgetin, microtubule severing factor | 2 | 8 | ||||||||
MIRT507680 | COIL | coilin | 2 | 6 | ||||||||
MIRT508394 | C1orf210 | chromosome 1 open reading frame 210 | 2 | 6 | ||||||||
MIRT508658 | DIABLO | diablo IAP-binding mitochondrial protein | 2 | 4 | ||||||||
MIRT508925 | AK4 | adenylate kinase 4 | 2 | 4 | ||||||||
MIRT510382 | ZNF566 | zinc finger protein 566 | 2 | 6 | ||||||||
MIRT511379 | IKZF3 | IKAROS family zinc finger 3 | 2 | 4 | ||||||||
MIRT512738 | CD59 | CD59 molecule (CD59 blood group) | 2 | 4 | ||||||||
MIRT516076 | ZBTB8OS | zinc finger and BTB domain containing 8 opposite strand | 2 | 4 | ||||||||
MIRT520035 | YOD1 | YOD1 deubiquitinase | 2 | 6 | ||||||||
MIRT521379 | RDX | radixin | 2 | 4 | ||||||||
MIRT523609 | FZD9 | frizzled class receptor 9 | 2 | 4 | ||||||||
MIRT523970 | DVL3 | dishevelled segment polarity protein 3 | 2 | 2 | ||||||||
MIRT524100 | DNA2 | DNA replication helicase/nuclease 2 | 2 | 2 | ||||||||
MIRT525720 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT529720 | OPRL1 | opioid related nociceptin receptor 1 | 2 | 2 | ||||||||
MIRT533174 | WASL | Wiskott-Aldrich syndrome like | 2 | 6 | ||||||||
MIRT536371 | LEFTY1 | left-right determination factor 1 | 2 | 2 | ||||||||
MIRT541383 | CDKN1A | cyclin dependent kinase inhibitor 1A | 2 | 2 | ||||||||
MIRT542687 | SALL3 | spalt like transcription factor 3 | 2 | 2 | ||||||||
MIRT543861 | SLC16A9 | solute carrier family 16 member 9 | 2 | 2 | ||||||||
MIRT545380 | PM20D2 | peptidase M20 domain containing 2 | 2 | 2 | ||||||||
MIRT545851 | ZNF264 | zinc finger protein 264 | 2 | 4 | ||||||||
MIRT545877 | ZNF200 | zinc finger protein 200 | 2 | 4 | ||||||||
MIRT546322 | TGFBR3 | transforming growth factor beta receptor 3 | 2 | 2 | ||||||||
MIRT546645 | RRM2 | ribonucleotide reductase regulatory subunit M2 | 2 | 2 | ||||||||
MIRT547363 | MSI2 | musashi RNA binding protein 2 | 2 | 2 | ||||||||
MIRT547564 | LRIG3 | leucine rich repeats and immunoglobulin like domains 3 | 2 | 4 | ||||||||
MIRT547828 | IGF2BP3 | insulin like growth factor 2 mRNA binding protein 3 | 2 | 4 | ||||||||
MIRT548258 | FBXL20 | F-box and leucine rich repeat protein 20 | 2 | 2 | ||||||||
MIRT548331 | EPHA4 | EPH receptor A4 | 2 | 2 | ||||||||
MIRT548526 | DUSP1 | dual specificity phosphatase 1 | 2 | 2 | ||||||||
MIRT549016 | CBX5 | chromobox 5 | 2 | 2 | ||||||||
MIRT549200 | BEND4 | BEN domain containing 4 | 2 | 4 | ||||||||
MIRT549756 | ZNF611 | zinc finger protein 611 | 2 | 6 | ||||||||
MIRT549792 | KIAA0391 | KIAA0391 | 2 | 2 | ||||||||
MIRT549840 | ECHDC1 | ethylmalonyl-CoA decarboxylase 1 | 2 | 2 | ||||||||
MIRT550720 | PMPCA | peptidase, mitochondrial processing alpha subunit | 2 | 4 | ||||||||
MIRT550891 | ACTA1 | actin, alpha 1, skeletal muscle | 2 | 2 | ||||||||
MIRT551276 | MCF2L2 | MCF.2 cell line derived transforming sequence-like 2 | 2 | 6 | ||||||||
MIRT551311 | GSG2 | histone H3 associated protein kinase | 2 | 6 | ||||||||
MIRT551925 | AKAP8 | A-kinase anchoring protein 8 | 2 | 4 | ||||||||
MIRT552403 | ZNF460 | zinc finger protein 460 | 2 | 4 | ||||||||
MIRT552463 | ZNF280B | zinc finger protein 280B | 2 | 2 | ||||||||
MIRT555533 | PLEKHA3 | pleckstrin homology domain containing A3 | 2 | 2 | ||||||||
MIRT555692 | PEX11B | peroxisomal biogenesis factor 11 beta | 2 | 2 | ||||||||
MIRT555697 | PDZD8 | PDZ domain containing 8 | 2 | 2 | ||||||||
MIRT556036 | MXD1 | MAX dimerization protein 1 | 2 | 2 | ||||||||
MIRT556264 | MAPK6 | mitogen-activated protein kinase 6 | 2 | 2 | ||||||||
MIRT557366 | HAND1 | heart and neural crest derivatives expressed 1 | 2 | 2 | ||||||||
MIRT557947 | FAM222B | family with sequence similarity 222 member B | 2 | 2 | ||||||||
MIRT558792 | CDV3 | CDV3 homolog | 2 | 2 | ||||||||
MIRT561769 | PEG10 | paternally expressed 10 | 2 | 2 | ||||||||
MIRT564395 | EMILIN2 | elastin microfibril interfacer 2 | 2 | 4 | ||||||||
MIRT565223 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT565437 | SURF4 | surfeit 4 | 2 | 2 | ||||||||
MIRT566494 | PBX2P1 | PBX homeobox 2 pseudogene 1 | 2 | 2 | ||||||||
MIRT566511 | PARP16 | poly(ADP-ribose) polymerase family member 16 | 2 | 2 | ||||||||
MIRT567315 | HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 | 2 | 2 | ||||||||
MIRT567708 | E2F6 | E2F transcription factor 6 | 2 | 2 | ||||||||
MIRT568320 | BACH1 | BTB domain and CNC homolog 1 | 2 | 2 | ||||||||
MIRT568644 | ABHD17C | abhydrolase domain containing 17C | 2 | 2 | ||||||||
MIRT569491 | THYN1 | thymocyte nuclear protein 1 | 2 | 2 | ||||||||
MIRT573813 | TGOLN2 | trans-golgi network protein 2 | 2 | 2 | ||||||||
MIRT574356 | ZBTB37 | zinc finger and BTB domain containing 37 | 2 | 2 | ||||||||
MIRT574744 | GOLGA4 | golgin A4 | 2 | 2 | ||||||||
MIRT576071 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT576789 | Thbs1 | thrombospondin 1 | 2 | 3 | ||||||||
MIRT616363 | RWDD1 | RWD domain containing 1 | 2 | 2 | ||||||||
MIRT642387 | ZNF556 | zinc finger protein 556 | 2 | 2 | ||||||||
MIRT650257 | ARHGAP22 | Rho GTPase activating protein 22 | 2 | 2 | ||||||||
MIRT680512 | PRIM2 | DNA primase subunit 2 | 2 | 2 | ||||||||
MIRT680540 | ZNF584 | zinc finger protein 584 | 2 | 2 | ||||||||
MIRT680831 | ARL8B | ADP ribosylation factor like GTPase 8B | 2 | 2 | ||||||||
MIRT681264 | RFC2 | replication factor C subunit 2 | 2 | 2 | ||||||||
MIRT681352 | BRI3BP | BRI3 binding protein | 2 | 2 | ||||||||
MIRT681499 | STAT2 | signal transducer and activator of transcription 2 | 2 | 2 | ||||||||
MIRT681529 | ZNF738 | zinc finger protein 738 | 2 | 2 | ||||||||
MIRT681651 | DTX3L | deltex E3 ubiquitin ligase 3L | 2 | 2 | ||||||||
MIRT681755 | CDKAL1 | CDK5 regulatory subunit associated protein 1 like 1 | 2 | 2 | ||||||||
MIRT681790 | EIF4A3 | eukaryotic translation initiation factor 4A3 | 2 | 2 | ||||||||
MIRT681935 | SLC19A3 | solute carrier family 19 member 3 | 2 | 2 | ||||||||
MIRT682095 | ITGA3 | integrin subunit alpha 3 | 2 | 4 | ||||||||
MIRT682174 | SLC38A7 | solute carrier family 38 member 7 | 2 | 2 | ||||||||
MIRT682231 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT682378 | PHACTR4 | phosphatase and actin regulator 4 | 2 | 2 | ||||||||
MIRT682589 | CPA4 | carboxypeptidase A4 | 2 | 2 | ||||||||
MIRT682633 | COX6B1 | cytochrome c oxidase subunit 6B1 | 2 | 2 | ||||||||
MIRT689320 | FPR1 | formyl peptide receptor 1 | 2 | 2 | ||||||||
MIRT689723 | ATXN2 | ataxin 2 | 2 | 2 | ||||||||
MIRT691029 | ZNF799 | zinc finger protein 799 | 2 | 2 | ||||||||
MIRT691928 | DNAJC28 | DnaJ heat shock protein family (Hsp40) member C28 | 2 | 2 | ||||||||
MIRT694877 | ZNF417 | zinc finger protein 417 | 2 | 2 | ||||||||
MIRT695248 | ZNF443 | zinc finger protein 443 | 2 | 2 | ||||||||
MIRT701422 | NHLRC2 | NHL repeat containing 2 | 2 | 2 | ||||||||
MIRT701992 | MIER3 | MIER family member 3 | 2 | 2 | ||||||||
MIRT702477 | KIAA1328 | KIAA1328 | 2 | 2 | ||||||||
MIRT702701 | IPO9 | importin 9 | 2 | 2 | ||||||||
MIRT704022 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | 2 | 2 | ||||||||
MIRT712363 | NAP1L1 | nucleosome assembly protein 1 like 1 | 2 | 2 | ||||||||
MIRT712448 | KHNYN | KH and NYN domain containing | 2 | 2 | ||||||||
MIRT713513 | PAFAH2 | platelet activating factor acetylhydrolase 2 | 2 | 2 | ||||||||
MIRT731769 | PDCD4 | programmed cell death 4 | 3 | 1 | ||||||||
MIRT733048 | TLR4 | toll like receptor 4 | 1 | 0 | ||||||||
MIRT733831 | BDNF | brain derived neurotrophic factor | 3 | 0 | ||||||||
MIRT737334 | HK2 | hexokinase 2 | 3 | 0 | ||||||||
MIRT756084 | MMP11 | matrix metallopeptidase 11 | 3 | 1 | ||||||||
MIRT756086 | FN1 | fibronectin 1 | 2 | 1 | ||||||||
MIRT756087 | COL6A1 | collagen type VI alpha 1 chain | 2 | 1 | ||||||||
MIRT756088 | COL6A2 | collagen type VI alpha 2 chain | 2 | 1 | ||||||||
MIRT756089 | COL6A3 | collagen type VI alpha 3 chain | 2 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|